Comparative analysis of LVAD patients in regard of ischaemic or idiopathic cardiomyopathy: A propensity-score analysis of EUROMACS data
- 3 February 2022
- journal article
- research article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 45 (3) , 284-291
Abstract
Background: Despite recent advances in management of patients with advanced heart failure, mortality remains high. Aim of this study was to compare impact of different aetiology of ischaemic and idiopathic cardiomyopathy on early outcomes and long-term survival of patients after left ventricular assist device implantation. Methods: European Registry for Patients with Mechanical Circulatory Support (EUROMACS) gathers clinical data and follow-up parameters of LVAD recipients. Patients enrolled in the EUROMACS registry with primary diagnosis of either ischaemic ( n = 1190) or idiopathic ( n = 812) cardiomyopathy were included. Primary Endpoints were early mortality as well as long-term survival. Secondary endpoint were major postoperative adverse events, such as need for rethoracotomy. Additionally, a propensity-score matching analysis was performed for patients with ischaemic ( n = 509) and idiopathic ( n = 509) cardiomyopathy. Results: In terms of basic demographics and baseline parameters the two groups significantly differed as expected before propensity-score matching due to different aetiology of cardiomyopathy. Seven-day (52 (4.4%) versus 18 (2.2%); p = 0.009), 30-day (153 (12.9%) versus 73 (9.0%); p = 0.008) and in-hospital mortality (253 (19.7%) versus 123 (15.1%); p = 0.009) were significantly lower in the idiopathic cardiomyopathy group compared to the ischaemic cardiomyopathy group, whereas after propensity-score matching 30-day ( p = 0.169) was comparable and in-hospital mortality ( p = 0.051) was almost significant. Kaplan-Meier survival analysis revealed no significant difference in regard of long-term survival after propensity-score matching (Breslow-test p = 0.161 and LogRank-test p = 0.113). Conclusion: Though patients with ischaemic and idiopathic cardiomyopathy suffer from different cardiomyopathy aetiologies, 30-day-mortality and long-term survival of both groups were similar leading to the conclusion that covariates predominately influence mortality and survival of ischaemic and idiopathic cardiomyopathies.Keywords
Funding Information
- European Association for Cardio-Thoracic Surgery
This publication has 30 references indexed in Scilit:
- Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of CardiomyopathyJACC: Heart Failure, 2015
- Contemporary Outcome in Patients With Idiopathic Dilated CardiomyopathyThe American Journal of Cardiology, 2015
- The European Registry for Patients with Mechanical Circulatory Support (EUROMACS): first annual reportEuropean Journal of Cardio-Thoracic Surgery, 2015
- Diagnosis and management of ischemic cardiomyopathy: Role of cardiovascular magnetic resonance imagingWorld Journal of Cardiology, 2014
- Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapiesWorld Journal of Cardiology, 2014
- Improving Survival Rates of Patients With Idiopathic Dilated Cardiomyopathy in Tuscany Over 3 DecadesCirculation: Heart Failure, 2013
- Ischemic Versus Nonischemic Dilated CardiomyopathyASAIO Journal, 2013
- Idiopathic dilated cardiomyopathy: possible triggers and treatment strategiesNetherlands Heart Journal, 2012
- INTERMACS Database for Durable Devices for Circulatory Support: First Annual ReportThe Journal of Heart and Lung Transplantation, 2008
- A standardized definition of ischemic cardiomyopathy for use in clinical researchJACC, 2002